Zylo Therapeutics has experienced steady progress in product and partner development over the last 6 years as they approach their first year of revenue. CEO Scott Pancoast updates us on a very exciting partnership opportunity in the anti-aging space that will come to market in January 2024. He reviews all the other progress, the various other products in development and the future revenue stream. He also talks about potentially spinning out the Pharma part of the business to a larger partner and focusing on the non-Pharma products and partners that have seen success.
Follow David on X at https://x.com/DGRollingSouth
Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/
Follow Paul on X at https://x.com/PalmettoAngel
Connect On LinkedIn with Paul at
https://www.linkedin.com/in/paulclarkprivateequity/
We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com.
